MRN set for expansion with £3m investment from Shawbrook Bank
Clinical trials specialist Medical Research Network Ltd (MRN) has announced plans to extend its geographic footprint following a new funding round, including a £3m...
Medica moves into global clinical trials market with US acquisition
London listed teleradiology provider Medica Group has agreed to acquire US-based imaging contract research organisation (iCRO) RadMD, paving its way for entry into the $1bn global...
Infrastructure fund invests in Rutherford Health
Cancer treatment specialist Rutherford Health plc has agreed a £40m infrastructure investment with Equitix Investment Management Ltd.
Under the deal, the freehold for Rutherford Cancer...
Membership-based primary care clinic opens in London
Membership-based private primary care provider (med)24 has announced the opening of its flagship clinic in London’s Paddington on 29 March.
The 7,000sqft facility will be open...
Income dips at St Andrew’s Healthcare
Increased pressure on public spending has continued to dampen revenue at St Andrew’s Healthcare (STAH) as the charitable mental health provider reported a £1m...
Practice Plus Group announces first set of results as standalone business
Care UK’s former healthcare division Practice Plus Group has reported ‘good performance’ in 2020 despite operational challenges created by the Covid-19 pandemic.
The company was...
Apposite Capital sells MiHomecare and Complete Care
City & County Healthcare Group has purchased MiHomecare and Complete Care Amegreen from private equity firm Apposite Capital.
MiHomecare, which includes Noble Live-In Care, provides...
Bupa Global and UK profits dip due to Covid closures
Reduced revenue from healthcare services and insurance premium rebates paid to customers as a result of the Covid-19 pandemic have dented UK profits at...
Affidea ramps up UK entry with Orthoderm acquisition
Affidea Group, Europe’s largest medical services provider, has announced its second UK acquisition in the space of a week after taking over Belfast-based Orthoderm.
Financial...
Spire ‘cautiously optimistic’ as FY20 results exceed analysts’ expectations
Spire Healthcare said today that it is ‘cautiously optimistic’ trading will return to pre-pandemic levels in 2021 as it reported FY20 results ahead of...
©2024 All rights reserved LaingBuisson 